Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Demarest

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Journal of Virology|May 28, 2003
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease geneAnnika C Karlsson, Steven G Deeks, Jason D Barbour, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failureLuke C Swenson, Celia K S Chui, Chanson J Brumme, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.
Nature Reviews. Drug Discovery|December 2, 2024
Antiviral target compound profile for pandemic preparednessJames F Demarest, Ruxandra Draghia-Akli, Tomas Cihlar, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Journal of Virology|May 28, 2003
Dual pressure from antiretroviral therapy and cell-mediated immune response on the human immunodeficiency virus type 1 protease geneAnnika C Karlsson, Steven G Deeks, Jason D Barbour, et al.
Antimicrobial Agents and Chemotherapy|October 2, 2013
Genotypic analysis of the V3 region of HIV from virologic nonresponders to maraviroc-containing regimens reveals distinct patterns of failureLuke C Swenson, Celia K S Chui, Chanson J Brumme, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.
Nature Reviews. Drug Discovery|December 2, 2024
Antiviral target compound profile for pandemic preparednessJames F Demarest, Ruxandra Draghia-Akli, Tomas Cihlar, et al.
Pageof 4